Estamos no ar no !
Saiba mais
Mentari Therapeutics, Inc. Common Stock
Sobre: Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP and PACAP pathways. The company's research and development activities focus on therapeutic candidates targeting PACAP and CGRP-related mechanisms for migraine prevention.
Notícias
Positiva
Neutra
Negativa
Sentimento
3 meses
Positiva
0%
Neutra
100%
Negativa
0%
Gráficos de preços implementados com Lightweight Charts™